Clinical Trial Update: Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament

View source ↗

Summary

Completed pharmacokinetic study of cycloserine, a second-line antituberculosis drug, in patients with pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Cycloserine (cycloserine)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Pulmonary Tuberculosis | Status: COMPLETED